Protara Therapeutics

ABOUT

Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead candidate, TARA-002, an investigational cell-based therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette-Guérin (BCG), as well as a Phase 2 trial in pediatric patients with LMs. Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral support who are otherwise unable to meet their choline needs via oral or enteral routes.

In this informative webinar, Dr. Alan Buchman, MD, MSPH, and Jacqueline Zummo, MPH, dive into:
✔️ Why choline is essential for those on TPN
✔️ The risks of deficiency and how it affects the body
✔️ What current research is showing
✔️ Steps patients and providers can take to ensure proper choline support
345 Park Avenue South, 3rd Floor
New York, NY 10010
  • Featured Employer
We are seeking highly motivated, skilled, agile, compassionate professionals to become an essential part of our growing team.


A career at Protara is an opportunity to join a vibrant company with a commitment to colleagues and culture. You will have the opportunity to be a part of a thriving team with an exciting mission. Anyone who possesses the skills, experience and requirements is invited to apply for the available positions below.
Our Mission

We are committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options.

Our Core Values

Excellence

Inclusivity

Integrity

Teamwork

Tenacity

Have Fun

At Protara, we support the people who make our work possible. Our benefits are designed to help you stay healthy, secure and balanced — both at work and at home.

We believe in creating a workplace that values integrity, inclusion and mutual respect. Protara is a place where motivated team players can have significant impact — and be supported along the way.
  • “Protara Therapeutics offers a truly unique and fulfilling work environment. The collaborative and supportive culture empowers us to drive meaningful progress in our development programs, knowing our work directly impacts patients facing significant medical challenges.”
    Hannah Fry | VP Controller, Finance & Accounting
  • “My favorite part about Protara is the team I have the privilege of working with every day. Despite being a small company, we accomplish major goals on a weekly, monthly and yearly basis because of our incredibly hardworking team. This work ethic can be seen from the top down. I am incredibly proud of every person I work with and couldn’t ask for a better group of people to push our potential therapies forward.”
    Brian Desch | Director, Clinical Operations
  • “I am thankful to work in a company that prioritizes integrity, innovation and collaboration towards making a meaningful impact on patients’ lives.”
    Flavia Ghiraldini | Senior Scientist
NEWS
Protara is advancing a cell therapy that triggers both adaptive and innate antitumor immune responses, while CG Oncology’s approach makes use of an oncolytic immunotherapy that preferentially targets cancer cells and proliferates inside them, destroying them from the inside.
JOBS
IN THE PRESS